Funny this came out today, i actually went into a skin clinic for my very mild rosacea ive had since birth.
there’s many treatments available (lasers, treatments etc) but it comes down to a good skincare routine.
mainly of which, would be to keep the skin clean and healthy (washing the dirt and keeping pores clear, vitamins etc)
so i’d say a huge part of the trial, or even past that, when prescribing it on a commercial / product basis (if passed) they SHOULD / would need to incorporate a healthy routine for the individual for best results.
think of it like, sure, cbd has been proven safe and reliable AND it works, but if the individual has clogged and disgusting oily / dirty skin / pores - they won’t ultimately get the best results. It’s basically sticking a helping solution on top of unfavourable / not optimal skin to be treated.
you would want the individual to have prepped and optimal skin for the trial. Atleast have every trial member wash their face and strip the skin of the dirt with some sort of deep clean / vitamins etc.
just my 2 cents (based on my rosacea consultation today)
- Forums
- ASX - By Stock
- BOT
- Ann: BTX 1702 Rosacea Study Approval
Ann: BTX 1702 Rosacea Study Approval, page-29
-
- There are more pages in this discussion • 73 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
SKS
SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne
Add BOT (ASX) to my watchlist
|
|||||
Last
38.0¢ |
Change
0.055(16.9%) |
Mkt cap ! $687.8M |
Open | High | Low | Value | Volume |
33.0¢ | 38.0¢ | 33.0¢ | $7.103M | 19.63M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 134000 | 37.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
38.0¢ | 650314 | 19 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 132500 | 0.375 |
3 | 7752 | 0.370 |
2 | 24000 | 0.365 |
1 | 4166 | 0.360 |
3 | 59669 | 0.355 |
Price($) | Vol. | No. |
---|---|---|
0.380 | 502144 | 15 |
0.385 | 164500 | 4 |
0.390 | 276986 | 11 |
0.395 | 750000 | 5 |
0.400 | 660032 | 20 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
SKS
SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne
BOT (ASX) Chart |